- Home
- CVKD vs LGL Comparison
CVKD vs LGL Comparison
Compare CVKD & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- LGL
- Stock Information
- Founded
- CVKD 2022
- LGL 1917
- Country
- CVKD United States
- LGL United States
- Employees
- CVKD N/A
- LGL N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- LGL Industrial Machinery/Components
- Sector
- CVKD Health Care
- LGL Technology
- Exchange
- CVKD Nasdaq
- LGL Nasdaq
- Market Cap
- CVKD 33.7M
- LGL 34.0M
- IPO Year
- CVKD 2023
- LGL N/A
- Fundamental
- Price
- CVKD $15.50
- LGL $6.72
- Analyst Decision
- CVKD Strong Buy
- LGL
- Analyst Count
- CVKD 1
- LGL 0
- Target Price
- CVKD $32.00
- LGL N/A
- AVG Volume (30 Days)
- CVKD 21.0K
- LGL 4.3K
- Earning Date
- CVKD 05-08-2025
- LGL 05-14-2025
- Dividend Yield
- CVKD N/A
- LGL N/A
- EPS Growth
- CVKD N/A
- LGL 59.20
- EPS
- CVKD N/A
- LGL 0.08
- Revenue
- CVKD N/A
- LGL $4,292,000.00
- Revenue This Year
- CVKD N/A
- LGL N/A
- Revenue Next Year
- CVKD N/A
- LGL N/A
- P/E Ratio
- CVKD N/A
- LGL $87.18
- Revenue Growth
- CVKD N/A
- LGL 16.69
- 52 Week Low
- CVKD $5.70
- LGL $4.86
- 52 Week High
- CVKD $22.90
- LGL $7.28
- Technical
- Relative Strength Index (RSI)
- CVKD 41.03
- LGL 49.34
- Support Level
- CVKD $15.29
- LGL $6.85
- Resistance Level
- CVKD $17.00
- LGL $7.08
- Average True Range (ATR)
- CVKD 0.80
- LGL 0.12
- MACD
- CVKD -0.02
- LGL 0.01
- Stochastic Oscillator
- CVKD 9.50
- LGL 37.93
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.